Your browser doesn't support javascript.
loading
Comparing Short- and Long-Term Treatment Duration of Bevacizumab for Advanced Ovarian Cancer.
Sun, Ryan; Huang, Bo; Wei, Lee-Jen.
Afiliação
  • Sun R; Ryan Sun, PhD, Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX; Bo Huang, PhD, Pfizer Inc, Groton, CT; and Lee-Jen Wei, PhD, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Huang B; Ryan Sun, PhD, Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX; Bo Huang, PhD, Pfizer Inc, Groton, CT; and Lee-Jen Wei, PhD, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Wei LJ; Ryan Sun, PhD, Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX; Bo Huang, PhD, Pfizer Inc, Groton, CT; and Lee-Jen Wei, PhD, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
J Clin Oncol ; 41(10): 1952-1953, 2023 04 01.
Article em En | MEDLINE | ID: mdl-36763910
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Duração da Terapia Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Duração da Terapia Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article